| Pasternak BA, D'Mello S, Jurickova II, et al.
Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | | Patel P, Barone F, Nunes C, et al.
Subepithelial dendritic B cells in orofacial granulomatosis. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | Find Related Articles | | Barreiro-de Acosta M, Magro F, Carpio D, et al.
Ulcerative colitis in northern Portugal and Galicia in Spain. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | | Ma Y, Guan Q, Bai A, et al.
Targeting TGF-beta1 by employing a vaccine ameliorates fibrosis in a mouse model of chronic colitis. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | | Parisinos CA, McIntyre VE, Heron T, et al.
Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: An observational, retrospective cohort study. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | Find Related Articles | | Behr MA
The path to Crohn's disease: Is mucosal pathology a secondary event? [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | Find Related Articles | | Stein DJ, Ananthakrishnan AN, Issa M, et al.
Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | | Hausmann J, Zabel K, Herrmann E, et al.
Methotrexate for maintenance of remission in chronic active Crohn's disease: Long-term single-center experience and meta-analysis of observational studies. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 18.
Abstract | Full Citation | | Masachs M, Casellas F, Borruel N, et al.
Validation of the Spanish version of a questionnaire to measure quality of care through the eyes of patients with inflammatory bowel disease (QUOTE-IBD). [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 16.
Abstract | Full Citation | | Sands BE, Jacobson EW, Sylwestrowicz T, et al.
Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 16.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
